Crescendo Partners, a Large Shareholder of Canaccord
Mar 10, 2023 · Canaccord Genuity 609 Granville Street Suite 2200 Vancouver, Canada V7Y 1H2. Dear Jill, Crescendo Partners and its affiliates (“Crescendo”) are large shareholders of Canaccord Genuity ...
Canaccord Genuity LLC support of Youth INC tops $5M
Jul 7, 2021 · Canaccord Genuity Capital Markets is the international capital markets division of Canaccord Genuity Group Inc. (TSX: CF), which offers mid-market institutional and corporate clients idea-driven ...
Elutia to Participate at the Canaccord Genuity MedTech,
Nov 13, 2024 · Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum November 13, 2024 16:05 ET | Source: Elutia Inc. Elutia Inc.
Biora Therapeutics Announces Participation in Canaccord Genuity ...
Feb 8, 2024 · Interested parties may contact their Canaccord Genuity representative to request registration details for the virtual event. About Biora Therapeutics Biora Therapeutics is reimagining therapeutic ...
electroCore to Participate in Canaccord Genuity’s MedTech,
ROCKAWAY, N.J., Nov. 07, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company,...
SOL Global Announces C$4 Million Brokered Private Placement
TORONTO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- SOL Global Investments Corp. (CSE: SOL; OTC Pink: SOLCF) (FSE: 9SB) (“SOL Global” or the “Company”) is pleased to announce that it has entered ...
Progyny, Inc. to Present at Canaccord Genuity MedTech,
Nov 10, 2023 · Progyny, Inc. to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum. November 10, 2023 12:00 ET | Source: Progyny. NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE ...
Exagen Inc. to Participate in the Canaccord Genuity 44th
CARLSBAD, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity 44 th ...
ASP Isotopes Inc. Responds to Short Seller Report - GlobeNewswire
Nov 26, 2024 · Canaccord Genuity’s analyst, George Gianarikas, will host a fire side chat with ASP Isotopes’s Chairman and Chief Executive Officer, Paul Mann, at 10am EST on November 27, 2024. Please contact ...
atai Life Sciences to Participate in the Canaccord Genuity
NEW YORK and BERLIN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment ...